BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33771116)

  • 1. Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial.
    Østergaard AM; Jørgensen AN; Bøvling S; Ekeløf NP; Mose FH; Bech JN
    BMC Nephrol; 2021 Mar; 22(1):111. PubMed ID: 33771116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
    Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
    PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
    Mose FH; Jörgensen AN; Vrist MH; Ekelöf NP; Pedersen EB; Bech JN
    BMC Nephrol; 2019 Jun; 20(1):200. PubMed ID: 31159750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults.
    Barnett AM; Babcock MC; Watso JC; Migdal KU; Gutiérrez OM; Farquhar WB; Robinson AT
    Am J Physiol Renal Physiol; 2022 Apr; 322(4):F392-F402. PubMed ID: 35157527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
    Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
    J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial.
    Weinberg L; Harris L; Bellomo R; Ierino FL; Story D; Eastwood G; Collins M; Churilov L; Mount PF
    Br J Anaesth; 2017 Oct; 119(4):606-615. PubMed ID: 29121282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
    Williams V; Jayashree M; Nallasamy K; Dayal D; Rawat A
    Crit Care; 2020 Jan; 24(1):1. PubMed ID: 31898531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial.
    Haase M; Haase-Fielitz A; Plass M; Kuppe H; Hetzer R; Hannon C; Murray PT; Bailey MJ; Bellomo R; Bagshaw SM
    PLoS Med; 2013; 10(4):e1001426. PubMed ID: 23610561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery.
    Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Mackle DM; Psirides AJ; Young PJ
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1630-1638. PubMed ID: 28774642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine biochemistry in septic and non-septic acute kidney injury: a prospective observational study.
    Bagshaw SM; Bennett M; Devarajan P; Bellomo R
    J Crit Care; 2013 Aug; 28(4):371-8. PubMed ID: 23159144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium Bicarbonate Supplementation and Urinary TGF-
    Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients.
    Verma B; Luethi N; Cioccari L; Lloyd-Donald P; Crisman M; Eastwood G; Orford N; French C; Bellomo R; Martensson J
    Crit Care Resusc; 2016 Sep; 18(3):205-12. PubMed ID: 27604335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
    Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery.
    Abassi Z; Shalabi A; Sohotnik R; Nativ O; Awad H; Bishara B; Frajewicki V; Sukhotnik I; Abbasi A; Nativ O
    J Urol; 2013 Apr; 189(4):1559-66. PubMed ID: 23085062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.
    Westhoff JH; Fichtner A; Waldherr S; Pagonas N; Seibert FS; Babel N; Tönshoff B; Bauer F; Westhoff TH
    Pediatr Nephrol; 2016 Dec; 31(12):2353-2363. PubMed ID: 27286687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment.
    Tidbury N; Browning N; Shaw M; Morgan M; Kemp I; Matata B
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):239-248. PubMed ID: 30987577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.